Importantly, the LIV-1 subfamily of ZIP transporters (including ZIP4, ZIP5, ZIP6, ZIP7, ZIP8, ZIP10, ZIP12, ZIP13, and ZIP14) has been implicated in a range of diseases, particularly cancer, where altered expression can influence zinc homeostasis and promote oncogenic signalling [22]. Here, SLC39A6 is linked to cancer.